Addendum to: Genetics in Medicine 12:742–745 (2010) https://doi.org/10.1097/GIM.0b013e3181f8baad, published online 18 October 2010.
This document was reaffirmed by the ACMG Board of Directors as of 27 April 2020 with the following addendum:
We suggest the following considerations in reaffirming this document:
-
1.
Since this document no longer meets the criteria for an evidence-based practice guideline by the College, it has been reclassified as a Clinical Practice Resource.
-
2.
Technical information for array-based testing may be referenced at the ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013.1
Reference
South ST, Lee C, Lamb AN, Working Group for the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee, et al. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med. 2013;15:901–909.
Author information
Authors and Affiliations
Consortia
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Correspondence: ACMG (documents@acmg.net)
Rights and permissions
About this article
Cite this article
Manning, M., Hudgins, L. & the American College of Medical Genetics and Genomics (ACMG) Professional Practice and Guidelines Committee. Addendum: Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 22, 2126 (2020). https://doi.org/10.1038/s41436-020-0848-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41436-020-0848-8